Profil
Hana Chen-Walden worked as the Director-International Regulatory Affairs at Covalent Group, Inc. from 2000 to 2003.
She then served as the Chief Medical Director at Boston Therapeutics, Inc. and as an Independent Director at BioXyTran, Inc. Dr. Chen-Walden holds a doctorate degree from Tel-Aviv University.
Anciens postes connus de Hana Chen-Walden
| Sociétés | Poste | Fin |
|---|---|---|
| BIOXYTRAN, INC. | Directeur/Membre du Conseil | 19/04/2024 |
Covalent Group, Inc.
Covalent Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research services to pharmaceutical, food and biotech companies | Conseiller Juridique Général | 01/01/2003 |
| NANOMIX CORPORATION | Directeur Technique/Scientifique/R&D | - |
Formation de Hana Chen-Walden
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Covalent Group, Inc.
Covalent Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research services to pharmaceutical, food and biotech companies | Commercial Services |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston Therapeutics, Inc.
Boston Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and commercializes pharmaceutical products | Health Technology |
BioXyTran, Inc.
BioXyTran, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that engages in the development, manufacture and commercialization of therapeutic drugs | Health Technology |
















